Trade Ipsen - IPN
Founded in 1929, Ipsen (IPN) is a leading international biopharmaceutical group, focusing on specialty care. The company develops and produces innovative medicines in 3 major areas: rare diseases, neurosciences and oncology. Ipsen also runs a consumer healthcare business. In general, the company sells over 20 drugs in more than 115 countries worldwide. Ipsen's R&D is focused on its differentiated and innovative technological platforms in the leading biotechnological hubs, based in Cambridge, the US, Oxford, the UK, and Paris-Saclay, France. Headquartered in Paris, the company employs 5,100 specialists. Included to the CAC Mid 60 index, the Ipsen share price (IPN) is set and traded on the Euronext Paris exchange.Latest shares articles

Cellnex stock forecast: BlackRock raises stake to 6.398%
Cellnex Telecom is a European telecom-infrastructure company listed in Madrid. In September, BlackRock raised its stake to 6.398% as Cellnex continued its share-buyback programme. Explore third-party CNLX price targets Past performance is not a reliable indicator of future results.
11 hours ago

Siemens stock forecast: VinSpeed high-speed rail contract
Siemens is a German industrial group with businesses across automation, infrastructure and mobility. On 22 September 2026, Siemens Mobility signed a high-speed rail contract with VinSpeed. Explore third-party SIE price targets. Past performance is not a reliable indicator of future results.
12 hours ago

DeFi Technologies stock forecast: Valour hedge fund launch
DeFi Technologies' subsidiary Valour launched its first hedge fund on 21 September 2026, expanding the business beyond exchange-traded products. Explore third-party DEFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago

Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026
Related News
GlobeNewswire•Europe
Reuters News•Europe
Reuters News•Europe
GlobeNewswire•Europe
Reuters News•Europe